Health Condition 1: null- All participant will either be ASA ( American Society of Anaesthesiologist ) grade 1 or 2
Conditions
Interventions
Intervention1: Dexmedetomidine: It is a highly selective α2 adrenergic receptor agonist, now emerging as an adjuvant to regional anaesthesia, where evolving studies can build evidence for its safe us
Sponsors
AIIMS Raipur
Eligibility
Inclusion criteria
Inclusion criteria: 1. ASA 1 or 2 patients 2. 18 - 60 yrs of age 3. Patient undergoing abdominal hysterectomy under subarachnoid block
Exclusion criteria
Exclusion criteria: a) Patients with contraindications for spinal anaesthesia b) ASA grade III and above c) Known allergy to any of the study medications d) Acute or chronic respiratory disease e) Hypertension or other cardiovascular abnormalities f) Cognitive or psychiatric disturbances g) Patients taking α adrenergic receptor antagonist, ACE inhibitors, angiotensin receptor blockers, chronic opioid therapy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| we will compare analgesic efficacy of two drugs which are used for control of pain for hysterectomyTimepoint: intraoperative and postoperative upto 24 hrs | — |
Secondary
| Measure | Time frame |
|---|---|
| Adverse effects Vital parametersTimepoint: Intraoperative and postoperative upto 24 hrs | — |
Countries
India
Contacts
Public ContactDr Mayank Kumar
AIIMS Raipur
Outcome results
None listed